Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance
Top Cited Papers
Open Access
- 1 August 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 106 (3), 812-817
- https://doi.org/10.1182/blood-2005-03-1038
Abstract
We hypothesized that the presence of monoclonal free kappa or lambda immunoglobulin light chains in monoclonal gammopathy of undetermined significancKeywords
This publication has 26 references indexed in Scilit:
- Multiple MyelomaNew England Journal of Medicine, 2004
- Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significanceBritish Journal of Haematology, 2004
- Long-term Follow-up of 241 Patients With Monoclonal Gammopathy of Undetermined Significance: The Original Mayo Clinic Series 25 Years LaterMayo Clinic Proceedings, 2004
- Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapyBritish Journal of Haematology, 2003
- Review of 1027 Patients With Newly Diagnosed Multiple MyelomaMayo Clinic Proceedings, 2003
- Prognostic Factors for Malignant Transformation in Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple MyelomaJournal of Clinical Oncology, 2002
- A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined SignificanceNew England Journal of Medicine, 2002
- MONOCLONAL GAMMOPATHIES OF UNDETERMINED SIGNIFICANCEHematology/Oncology Clinics of North America, 1999
- Monoclonal gammopathy of undetermined significanceAmerican Journal Of Medicine, 1978
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958